Science in Sport plc
("Science in Sport" or the "Company")
Director/PDMR Shareholding
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following transaction by a PDMR.
The information below set out in accordance with the requirement of the EU Market Abuse Regulation provides further detail.
| Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a. | Name | Lombard Odier Asset Management (Europe) Limited | ||||||
| 2 | Reason for notification |
| ||||||
| a. | Position/Status | PCA of Henry Turcan, Non-Executive Director | ||||||
| b. | Initial notification/ Amendment | Initial Notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a. | Name | Science in Sport plc | ||||||
| b. | LEI | 213800FWYWBJFJPPJ981 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a. | Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each | ||||||
| b. | Nature of the transaction | Purchase of shares
| ||||||
| c. | Price(s) and volume(s) | | | | | | ||
| | Price | Volume | | |||||
| 0.24 | 78,000 | | ||||||
| | | | | |||||
| | | | | |||||
| | | | | |||||
| | | | | |||||
| | | | | |||||
| | | | | |||||
| | | | | |||||
| | ||||||||
| d. | Aggregated information - Aggregated Volume - Price | n/a single transaction
| ||||||
| e. | Date of the transaction | 25 September 2024 | ||||||
| f. | Place of the transaction | Outside a trading venue | ||||||
For further information:
| Science in Sport plc | T: +44 (0) 20 7400 3700 |
| Daniel Wright, Executive Chairman Daniel Lampard, Chief Operating Officer Christopher Welsh, Chief Financial Officer
| |
| | |
| Panmure Liberum Limited (Nominated Adviser and Broker) | T: +44 (0) 20 3100 2000 |
| Richard Lindley John More Anake Singh
| |
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and eBay, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market.
PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart.
SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA.
SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs.
For further information, please visit phd.com and scienceinsport.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.